Clin2
NCT05656105Possibly a fitRecruiting

PET scan study of brain inflammation after COVID

SARS CoV-2 Post-Acute Sequelae

Treatments studied

Part of Brain & nervous system, Immune system & allergy, Infections clinical trials.

This early-phase study uses a special PET scan to look for signs of brain inflammation in people with ongoing (long-term) nervous system symptoms after COVID-19. It may help researchers understand what is driving symptoms and whether this imaging approach can detect inflammation.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
60 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old
  • You are either a person with post-COVID neurological symptoms (PASC) or a healthy control with no neurological symptoms
  • If you have PASC, your COVID infection was confirmed and your symptoms have lasted at least 4 weeks before joining
  • You must match the study’s genetic test results (TSPO binder type) for the PET imaging medicine
  • You must be able to do the scan safely, including having no MRI contraindications

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03759522Recruiting· Phase 1
PET brain scan for inflammation in MS, fibromyalgia, or CFS

This early-stage study tests an imaging medicine ([F-18]DPA-714) that can help researchers see inflammation in the brain and nervous system. It may help doctors better understand how “inflammation signals” differ across conditions like multiple sclerosis, fibromyalgia, and chronic fatigue syndrome.

Birmingham, Alabama
NCT03457493Recruiting· Phase 1/Phase 2
TSPO brain scan study in Parkinson’s disease

This trial looks at brain inflammation in people with Parkinson’s using a special PET scan. The goal is to understand how brain immune activity may relate to Parkinson’s, and how the scan results change over time.

Birmingham, Alabama
NCT06289582Recruiting· Early Phase 1
Brain imaging study for Parkinson's disease

This study uses a special PET scan to look at inflammation in the brain of people with Parkinson's disease or those at risk for it. The goal is to better understand the disease and possibly find new ways to track its progression.

Birmingham, Alabama
NCT06920628Recruiting· Phase 1
Brain scan study for long COVID neurological symptoms

This study uses a special PET scan to look at brain inflammation in people with neurological symptoms after COVID-19. It aims to understand how inflammation might be linked to ongoing problems like brain fog or memory issues.

Bethesda, Maryland
NCT07076862Recruiting· Early Phase 1
PET scan study for long COVID symptoms

This study uses a special PET scan to look at inflammation in the body of people with long COVID (symptoms lasting 3+ months after infection). The goal is to understand why symptoms persist and find better ways to help.

Sacramento, California
NCT07527130Not yet recruiting
Brain scan for inflammation in post-covid syndrome

This study uses a special PET scan to look for signs of inflammation in the brain that may be linked to long-lasting symptoms after COVID-19. The scan is a type of imaging that helps doctors see if there is ongoing inflammation, which could guide future treatments.

Rochester, Minnesota

Hear when a new SARS CoV-2 Post-Acute Sequelae trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.